Ortho Dermatologics announces U.S. FDA filing acceptance for IDP-121 acne treatment in lotion form. Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc., today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application for IDP-121 (tretinoin 0.05%) lotion (Altreno1) with a PDUFA action date of Aug. 27, 2018. If approved,…
FDA OKs Only OTC Eye Drop With Low-Dose Brimonidine For Redness
Bausch + Lomb receives FDA approval of Lumify — the only over-the-counter eye drop with low-dose brimonidine for the treatment of eye redness. Bausch + Lomb, a global eye health company and wholly owned subsidiary of Valeant Pharmaceuticals International, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved LUMIFY (brimonidine tartrate ophthalmic solution…